RFG Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.84M Buy
22,980
+2,582
+13% +$602K 0.09% 153
2026
Q1
$4.99M Buy
20,398
+1,307
+7% +$304K 0.09% 164
2025
Q4
$3.95M Buy
19,091
+456
+2% +$90.2K 0.07% 193
2025
Q3
$3.46M Buy
18,635
+1,538
+9% +$264K 0.07% 206
2025
Q2
$2.61M Sell
17,097
-1,181
-6% -$182K 0.06% 243
2025
Q1
$3.03M Buy
18,278
+1,515
+9% +$237K 0.08% 173
2024
Q4
$2.42M Buy
16,763
+691
+4% +$107K 0.07% 217
2024
Q3
$2.6M Sell
16,072
-2,422
-13% -$386K 0.08% 197
2024
Q2
$2.7M Buy
18,494
+1,336
+8% +$199K 0.09% 174
2024
Q1
$2.71M Sell
17,158
-1,316
-7% -$209K 0.09% 176
2023
Q4
$2.9M Sell
18,474
-284
-2% -$43.5K 0.11% 143
2023
Q3
$2.92M Buy
18,758
+2,102
+13% +$347K 0.13% 125
2023
Q2
$2.76M Sell
16,656
-8,467
-34% -$1.37M 0.12% 126
2023
Q1
$3.89M Buy
25,123
+2,385
+10% +$385K 0.19% 101
2022
Q4
$3.74M Buy
22,738
+304
+1% +$52.5K 0.19% 98
2022
Q3
$3.9M Buy
22,434
+594
+3% +$101K 0.22% 91
2022
Q2
$3.74M Sell
21,840
-1,381
-6% -$246K 0.22% 85
2022
Q1
$4.12M Sell
23,221
-219
-0.9% -$37.3K 0.26% 60
2021
Q4
$4.01M Buy
23,440
+3,635
+18% +$595K 0.28% 58
2021
Q3
$3.2M Buy
19,805
+112
+0.6% +$19.1K 0.26% 60
2021
Q2
$3.24M Buy
19,693
+4
+0% +$662 0.29% 56
2021
Q1
$3.24M Sell
19,689
-77
-0.4% -$12.5K 0.35% 46
2020
Q4
$3.16M Buy
19,766
+318
+2% +$46.9K 0.41% 48
2020
Q3
$2.9M Buy
19,448
+897
+5% +$133K 0.41% 48
2020
Q2
$2.61M Buy
18,551
+592
+3% +$86.3K 0.41% 47
2020
Q1
$2.35M Sell
17,959
-46
-0.3% -$6.53K 0.44% 45
2019
Q4
$2.63M Buy
18,005
+1,075
+6% +$146K 0.45% 42
2019
Q3
$2.19M Buy
16,930
+2,073
+14% +$273K 0.44% 47
2019
Q2
$2.07M Buy
14,857
+1,362
+10% +$189K 0.47% 47
2019
Q1
$1.89M Sell
13,495
-710
-5% -$95.1K 0.48% 43
2018
Q4
$1.83M Sell
14,205
-995
-7% -$139K 0.45% 39
2018
Q3
$2.1M Buy
15,200
+2,941
+24% +$391K 0.55% 40
2018
Q2
$1.49M Buy
12,259
+1,361
+12% +$170K 0.45% 41
2018
Q1
$1.4M Buy
10,898
+500
+5% +$67.6K 0.52% 34
2017
Q4
$1.47M Sell
10,398
-31
-0.3% -$4.32K 0.69% 31
2017
Q3
$1.39M Sell
10,429
-408
-4% -$54.1K 0.86% 22
2017
Q2
$1.43M Sell
10,837
-275
-2% -$35.1K 0.98% 16
2017
Q1
$1.39M Buy
11,112
+2,388
+27% +$285K 1.05% 16
2016
Q4
$1.04M Hold
8,724
0.99% 19
2016
Q3
$1.04M Buy
8,724
+888
+11% +$108K 0.95% 20
2016
Q2
$951K Buy
7,836
+373
+5% +$42.4K 0.83% 18
2016
Q1
$808K Buy
7,463
+2,068
+38% +$214K 0.63% 21
2015
Q4
$554K Sell
5,395
-193
-3% -$19.4K 0.41% 17
2015
Q3
$522K Sell
5,588
-4,925
-47% -$476K 1.68% 11
2015
Q2
$1.02M Buy
+10,513
New +$1.05M 0.46% 39

Other funds holding JNJ

RFG Advisory's JNJ Position: Q2 2026 in Review

RFG Advisory increased its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, buying an estimated $602K and bringing the position to 22,980 shares worth $5.84M. The position accounts for 0.09% of the portfolio, ranked #153.

RFG Advisory first reported a position in JNJ in Q2 2015 and has held it in 45 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • RFG Advisory held 22,980 shares of Johnson & Johnson worth $5.84M as of Q2 2026.
  • RFG Advisory bought 2,582 Johnson & Johnson shares in Q2 2026, an estimated $602K.
  • Johnson & Johnson made up 0.09% of RFG Advisory's portfolio in Q2 2026, its #153 holding.
  • RFG Advisory first reported a position in Johnson & Johnson in Q2 2015 and has held it in 45 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.